Ulcerative colitis trials in Lithuania

In Lithuania 9 Also abroad 382

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Klaipeda, Vilnius
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 2Taking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Kaunas, Klaipėda
Age
18 years to 80 years
People
1,431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Klaipeda, Vilnius
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Kaunas
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Phase 2Taking people
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Where
Kaunas, Klaipeda
Age
18 years and over
People
104 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-524404-29-00 · EU 2025-524404-29-00
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Kaunas, Panevezys
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 2Taking people
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Kaunas
Age
18 years and over
People
70 worldwide
Run by
Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Kaunas, Vilnius
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
Phase 2Taking people
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Kaunas
Age
18 years to 75 years
People
57 worldwide
Run by
Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727